Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma

PURPOSE: This paper is aimed at comparing the short-term efficacy of the combination of docetaxel, oxaliplatin, and capecitabine (DOX) with the combination of oxaliplatin and capecitabine (XELOX) as neoadjuvant chemotherapy regimens for the treatment of patients with resectable gastric or gastroesop...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Gastroenterol Res Pract
Hlavní autoři: Tian, Yuan, Zhao, Qun, Li, Yong, Fan, Liqiao, Zhang, Zhidong, Zhao, Xuefeng, Tan, Bibo, Wang, Dong, Yang, Peigang
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2021
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8324337/
https://ncbi.nlm.nih.gov/pubmed/34335737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/5590626
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky